down arrow

Indoco Remedies

26
Strong Sell
  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE873D01024
  • NSEID: INDOCO
  • BSEID: 532612
INR
232.20
6.7 (2.97%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 17.39 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Rs cr
Consolidated - Profit And Loss Results
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
Mar'19
No of Months
12
12
12
12
12
12
Operating Income
1,817.00
1,668.00
1,540.00
1,241.00
1,106.00
968.00
Less :Inter divisional transfers
0.00
0.00
0.00
0.00
0.00
0.00
Less: Excise
0.00
0.00
0.00
0.00
0.00
0.00
Net Sales
1,817.00
1,668.00
1,540.00
1,241.00
1,106.00
968.00
Expenditure (Ex Depriciation)
Stock Adjustments
-41.00
6.00
-26.00
-12.00
-8.00
13.00
Raw Materials Consumed
600.00
514.00
483.00
366.00
338.00
306.00
Power & Fuel Cost
55.00
50.00
42.00
36.00
34.00
28.00
Employee Cost
361.00
322.00
296.00
274.00
256.00
231.00
Operating Expenses
119.00
89.00
60.00
46.00
44.00
39.00
General and Administration Expenses
-1.00
-1.00
-1.00
-1.00
-1.00
-1.00
Selling and Distribution Expenses
175.00
141.00
117.00
112.00
122.00
93.00
Cost of Software developments
0.00
0.00
0.00
0.00
0.00
0.00
Miscellaneous Expenses
61.00
58.00
64.00
48.00
30.00
30.00
Expenses Capitalised
0.00
0.00
0.00
0.00
0.00
0.00
Total Expenditure
1,572.00
1,382.00
1,213.00
1,017.00
983.00
891.00
Operating Profit (PBDIT) excl Other Income
244.00
286.00
327.00
224.00
123.00
76.00
Other Income
9.00
2.00
2.00
3.00
2.00
6.00
Operating Profit (PBDIT)
254.00
288.00
329.00
227.00
125.00
82.00
Interest
38.00
25.00
14.00
22.00
26.00
20.00
Profit before Depriciation and Tax
216.00
263.00
315.00
205.00
99.00
62.00
Depreciation
91.00
70.00
78.00
73.00
70.00
71.00
Profit Before Taxation & Exceptional Items
124.00
192.00
236.00
131.00
28.00
-9.00
Exceptional Income / Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Profit Before Tax
135.00
192.00
236.00
131.00
28.00
-9.00
Provision for Tax
38.00
50.00
81.00
38.00
4.00
-6.00
Profit After Tax
97.00
142.00
154.00
93.00
24.00
-2.00
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Adj to Profit After Tax
0.00
0.00
0.00
0.00
0.00
0.00
Profit Balance B/F
686.00
563.00
428.00
338.00
319.00
334.00
Profit Available for appropriations
785.00
706.00
582.00
431.00
343.00
331.00
Appropriations
785.00
706.00
582.00
431.00
343.00
331.00
Equity Dividend (%)
75.00%
112.50%
112.50%
75.00%
15.00%
15.00%
Earnings Per Share
10.53
15.44
16.80
10.10
2.62
-0.32
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2024 is 8.91% vs 8.30% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2024 is -14.60% vs -12.60% in Mar 2023

stock-summary

Interest

YoY Growth in year ended Mar 2024 is 51.92% vs 76.99% in Mar 2023

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2024 is -31.81% vs -8.11% in Mar 2023

Compare Profit and Loss Results of Indoco Remedies
Markets Mojo
Figures in Rs cr
consolidated - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
1,817.00
10,334.00
-8,517.00
-82.42%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
1,817.00
10,334.00
-8,517.00
-82.42%
Expenditure (Ex Depriciation)
Stock Adjustments
-41.00
-94.00
53.00
56.38%
Raw Materials Consumed
600.00
3,263.00
-2,663.00
-81.61%
Power & Fuel Cost
55.00
129.00
-74.00
-57.36%
Employee Cost
361.00
2,274.00
-1,913.00
-84.12%
Operating Expenses
119.00
210.00
-91.00
-43.33%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
175.00
928.00
-753.00
-81.14%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
61.00
134.00
-73.00
-54.48%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
1,572.00
7,798.00
-6,226.00
-79.84%
Operating Profit (PBDIT) excl Other Income
244.00
2,536.00
-2,292.00
-90.38%
Other Income
9.00
280.00
-271.00
-96.79%
Operating Profit (PBDIT)
254.00
2,817.00
-2,563.00
-90.98%
Interest
38.00
35.00
3.00
8.57%
Profit before Depriciation and Tax
216.00
2,782.00
-2,566.00
-92.24%
Depreciation
91.00
398.00
-307.00
-77.14%
Profit Before Taxation & Exceptional Items
124.00
2,384.00
-2,260.00
-94.80%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
135.00
2,399.00
-2,264.00
-94.37%
Provision for Tax
38.00
457.00
-419.00
-91.68%
Profit After Tax
97.00
1,926.00
-1,829.00
-94.96%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
686.00
8,012.00
-7,326.00
-91.44%
Profit Available for appropriations
785.00
9,925.00
-9,140.00
-92.09%
Appropriations
785.00
9,925.00
-9,140.00
-92.09%
Equity Dividend (%)
75%
0%
75.00
Earnings Per Share
10.53
47.75
-37.22
-77.95%
Profit And Loss - Net Sales
Net Sales 1,817.29 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 8.91% vs 8.30% in Mar 2023

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 244.31 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -14.60% vs -12.60% in Mar 2023

Profit And Loss - Interest
Interest 38.02 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is 51.92% vs 76.99% in Mar 2023

Profit And Loss - Profit After Tax
Profit After Tax 97.00 Cr
in Mar 2024

Figures in Rs Cr
stock-summary

YoY Growth in year ended Mar 2024 is -31.81% vs -8.11% in Mar 2023